110 related articles for article (PubMed ID: 8610384)
1. The IgE humoral response in OKT3-treated patients. Incidence and fine specificity.
Abramowicz D; Crusiaux A; Niaudet P; Kreis H; Chatenoud L; Goldman M
Transplantation; 1996 Feb; 61(4):577-81. PubMed ID: 8610384
[TBL] [Abstract][Full Text] [Related]
2. The OKT3 Antibody Response Study: a multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ transplantation.
Kimball JA; Norman DJ; Shield CF; Schroeder TJ; Lisi P; Garovoy M; O'Connell JB; Stuart F; McDiarmid SV; Wall W
Transpl Immunol; 1995 Sep; 3(3):212-21. PubMed ID: 8581409
[TBL] [Abstract][Full Text] [Related]
3. Characterization of anti-thymoglobulin, anti-Atgam and anti-OKT3 IgG antibodies in human serum with an 11-min ELISA.
Regan J; Campbell K; van Smith L; Pouletty P; Schroeder TJ; Guttmann RD; Buelow R
Transpl Immunol; 1997 Mar; 5(1):49-56. PubMed ID: 9106335
[TBL] [Abstract][Full Text] [Related]
4. Development of anti-OKT3 antibodies after OKT3 treatment.
Jensen PB; Birkeland SA; Rohrp N; Elbirk A; Jørgensen KA
Scand J Urol Nephrol; 1996 Jun; 30(3):227-30. PubMed ID: 8837256
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression.
Jaffers GJ; Fuller TC; Cosimi AB; Russell PS; Winn HJ; Colvin RB
Transplantation; 1986 May; 41(5):572-8. PubMed ID: 3085297
[TBL] [Abstract][Full Text] [Related]
6. Prediction of successful allograft rejection retreatment with OKT3.
Legendre C; Kreis H; Bach JF; Chatenoud L
Transplantation; 1992 Jan; 53(1):87-90. PubMed ID: 1733090
[TBL] [Abstract][Full Text] [Related]
7. Detection of IGA anti-OKT3 antibodies in OKT3-treated transplant recipients.
McIntyre JA; Kincade M; Higgins NG
Transplantation; 1996 May; 61(10):1465-9. PubMed ID: 8633372
[TBL] [Abstract][Full Text] [Related]
8. Cross-species reactivity of the anti-idiotype anti-OKT3 cascade between mice and humans.
Carreno M; Fuller L; Zucker K; Yang WC; Burke G; Nery J; Gomez C; Esquenazi V; Miller J
Hum Immunol; 1992 Apr; 33(4):249-58. PubMed ID: 1386353
[TBL] [Abstract][Full Text] [Related]
9. Antibody response to OKT3 and methods for monitoring.
Schroeder TJ; Hariharan S; First MR
Transplant Proc; 1993 Apr; 25(2 Suppl 1):77-80. PubMed ID: 8465433
[TBL] [Abstract][Full Text] [Related]
10. Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3.
Chatenoud L; Baudrihaye MF; Chkoff N; Kreis H; Goldstein G; Bach JF
J Immunol; 1986 Aug; 137(3):830-8. PubMed ID: 3487589
[TBL] [Abstract][Full Text] [Related]
11. Anti-OKT3 response following prophylactic treatment in paediatric kidney transplant recipients.
Niaudet P; Jean G; Broyer M; Chatenoud L
Pediatr Nephrol; 1993 Jun; 7(3):263-7. PubMed ID: 8518095
[TBL] [Abstract][Full Text] [Related]
12. Immunologic monitoring during OKT3 therapy.
Chatenoud L
Clin Transplant; 1993 Aug; 7(4 Pt 2):422-30. PubMed ID: 10146352
[TBL] [Abstract][Full Text] [Related]
13. Immunologic monitoring of OKT3 induction therapy in cardiac allograft recipients.
Toyoda M; Galfayan K; Wachs K; Czer L; Jordan SC
Clin Transplant; 1995 Dec; 9(6):472-80. PubMed ID: 8645891
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of anti-OKT3 antibodies with the Transtat assay.
Schroeder TJ; First MR; Pouletty C; Hariharan S; Pouletty P
Transplantation; 1993 Feb; 55(2):297-9. PubMed ID: 8434379
[TBL] [Abstract][Full Text] [Related]
15. OKT3 induction via idiotypic networks of mirror-image immunosuppressive antiimmunoglobulins in renal transplant recipients.
Carreno M; Yang WC; Esquenazi V; Fuller L; Burke G; Milgrom M; Roth D; Ranjan D; Miller J
Transplantation; 1990 Feb; 49(2):408-15. PubMed ID: 1689519
[TBL] [Abstract][Full Text] [Related]
16. Anaphylactic shock caused by immunoglobulin E sensitization after retreatment with the chimeric anti-interleukin-2 receptor monoclonal antibody basiliximab.
Baudouin V; Crusiaux A; Haddad E; Schandene L; Goldman M; Loirat C; Abramowicz D
Transplantation; 2003 Aug; 76(3):459-63. PubMed ID: 12923429
[TBL] [Abstract][Full Text] [Related]
17. OKT3 induction in pediatric renal transplantation.
Bartosh SM; Aronson AJ; Swanson-Pewitt EE; Thistlethwaite JR
Pediatr Nephrol; 1993 Feb; 7(1):45-9. PubMed ID: 8382505
[TBL] [Abstract][Full Text] [Related]
18. OKT3 antibody response study: comparative testing of human antimouse antibody.
Kimball JA; Norman DJ; Shield CF; Schroeder TJ; Lisi P; Garovoy M; O'Connell JB; Stuart F; McDiarmid SV; Wall W
Transplant Proc; 1993 Apr; 25(2 Suppl 1):74-6. PubMed ID: 8465432
[No Abstract] [Full Text] [Related]
19. Clinical role of immunologic monitoring during OKT3 treatment.
Bhat G; Schroeder TJ
Transplant Proc; 1997 Dec; 29(8A):21S-26S. PubMed ID: 9414670
[No Abstract] [Full Text] [Related]
20. Induction of high titers of anti-IgE by immunization of inbred mice with syngeneic IgE.
Haba S; Nisonoff A
Proc Natl Acad Sci U S A; 1987 Jul; 84(14):5009-13. PubMed ID: 2440038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]